SCHEMBL5560697

SCHEMBL5560697

O=C1CC(c2cccc([N+](=O)[O-])c2)=NN1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.57
MAPT P10636 4/20 0.52
PGR P06401 2/20 0.52
TDP2 O95551 3/20 0.50
LMNA P02545 5/20 0.48
ALDH1A1 P00352 3/20 0.48
IDO1 P14902 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
TSHR P16473 1/20 0.46
PSMB8 P28062 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
GUSB P08236 1/20 0.44
MEN1 O00255 1/20 0.44
ELANE P08246 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11624623 0.87 SMN1; SMN2 (0.58) MAPTPGRTDP2LMNAALDH1A1
SCHEMBL5560748 0.81 AXL (0.59) AXLMAPTTDP2LMNAALDH1A1
SCHEMBL10803263 0.80 MAPT (0.50) MAPTPGRTDP2LMNAALDH1A1
SCHEMBL8450867 0.79 PDE3B (0.53) MAPT
SCHEMBL27995075 0.76 AXL (0.77) AXLTDP2ALDH1A1SMN1; SMN2PSMB8
SCHEMBL1422939 0.75 ALDH1A1 (0.65) MAPTPGRTDP2ALDH1A1SMN1; SMN2
SCHEMBL2892328 0.74 AXL (0.46) AXLMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL11624276 0.74 GALR3 (0.67) MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL2299377 0.74 PGR (0.56) MAPTPGRTDP2ALDH1A1MEN1
SCHEMBL22348268 0.73 SMN1; SMN2 (0.49) MAPTPGRTDP2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 US disclosed
EP-1119567-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2001-08-01 EP disclosed
WO-2000021955-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-04-20 WO disclosed